Edwards Lifesciences stock dipped Thursday after the FDA recalled the company's heart-valve replacement, or TAVR, system following several injuries and a patient death during implantation.

source https://finance.yahoo.com/m/cafabdc5-8e04-36ca-b987-7997280f8cfb/this-ibd-50-stock-is-facing.html?.tsrc=rss